Dizal Pharma
Dizal Pharma provides end‑to‑end outsourced services for drug development and manufacturing, covering everything from early‑stage formulation and clinical trial material production to commercial‑scale GMP manufacturing. Their integrated platform combines formulation science, process optimization, regulatory support, analytical testing, and supply‑chain logistics to accelerate time‑to‑market while ensuring compliance and consistent product quality for pharma innovators, biotech firms, and generic manufacturers.
- Biotechnology
- Healthcare Technology
Funding
Raised to date
$246.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Founder details are not available yet.
Product
Problem
Pharmaceutical companies often face challenges in efficiently developing and delivering high-quality medicines due to complex regulatory requirements, lengthy development cycles, and the need for reliable manufacturing processes.
Solution
Dizal Pharma offers end-to-end pharmaceutical services that streamline drug development from early-stage research through commercial manufacturing. The company integrates advanced formulation science, process optimization, and regulatory expertise to accelerate time‑to‑market while maintaining strict quality standards. By leveraging scalable production facilities and a robust quality management system, Dizal Pharma ensures consistent batch release and compliance with global regulatory frameworks. Clients receive comprehensive project support, including analytical testing, packaging, and logistics, enabling them to focus on therapeutic innovation.
Target Audience
Primary customers are pharmaceutical innovators, biotech firms, and generic drug manufacturers seeking outsourced development and manufacturing solutions.
Features
- Integrated drug development platform covering preclinical formulation, clinical trial material production, and commercial scale-up
- GMP‑certified manufacturing facilities with flexible batch sizes for small molecules and biologics
- In‑house analytical labs providing stability testing, bioavailability studies, and release assays
- Regulatory affairs team managing IND, NDA, and post‑approval submissions across major markets
- End-to-end supply chain services including packaging, labeling, and distribution logistics